Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1998 Dec;63(6):1724–1731. doi: 10.1086/302162

The gene for human fibronectin glomerulopathy maps to 1q32, in the region of the regulation of complement activation gene cluster.

M Vollmer 1, M Jung 1, F Rüschendorf 1, R Ruf 1, T Wienker 1, A Reis 1, R Krapf 1, F Hildebrandt 1
PMCID: PMC1377644  PMID: 9837825

Abstract

Fibronectin glomerulopathy (GFND) is a newly recognized autosomal dominant disease of the kidney that results in albuminuria, microscopic hematuria, hypertension, renal tubular acidosis type IV, and end-stage renal disease in the 2d to 6th decade of life. The disease is characterized histologically by massive deposits of fibronectin (Fn) present in the subendothelial spaces of renal glomerular capillaries. The cause of human GFND is unknown. In order to localize a candidate gene for GFND, we performed linkage analysis of a large, 193-member pedigree containing 13 affected individuals. Since we had previously excluded the genes for Fn and uteroglobin as candidate genes for GFND, a total-genome search for linkage was performed. Examination of 306 microsatellite markers resulted in a maximum two-point LOD score of 4.17 at a recombination fraction of. 00 for marker D1S249, and a maximum multipoint LOD score of 4.41 for neighboring marker D1S2782. By detection of recombination events, a critical genetic interval of 4.1 cM was identified, which was flanked by markers D1S2872 and D1S2891. These findings confirm that GFND is a distinct disease entity among the fibrillary glomerulopathies. Gene identification will provide insights into the molecular interactions of Fn in GFND, as well as in genetically unaltered conditions.

Full Text

The Full Text of this article is available as a PDF (331.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abt A. B., Wassner S. J., Moran J. J. Familial lobular glomerulopathy. Hum Pathol. 1991 Aug;22(8):825–829. doi: 10.1016/0046-8177(91)90212-8. [DOI] [PubMed] [Google Scholar]
  2. Alpers C. E. Immunotactoid (microtubular) glomerulopathy: an entity distinct from fibrillary glomerulonephritis? Am J Kidney Dis. 1992 Feb;19(2):185–191. doi: 10.1016/s0272-6386(12)70132-4. [DOI] [PubMed] [Google Scholar]
  3. Alpers C. E., Rennke H. G., Hopper J., Jr, Biava C. G. Fibrillary glomerulonephritis: an entity with unusual immunofluorescence features. Kidney Int. 1987 Mar;31(3):781–789. doi: 10.1038/ki.1987.66. [DOI] [PubMed] [Google Scholar]
  4. Assmann K. J., Koene R. A., Wetzels J. F. Familial glomerulonephritis characterized by massive deposits of fibronectin. Am J Kidney Dis. 1995 May;25(5):781–791. doi: 10.1016/0272-6386(95)90555-3. [DOI] [PubMed] [Google Scholar]
  5. Ault B. H., Schmidt B. Z., Fowler N. L., Kashtan C. E., Ahmed A. E., Vogt B. A., Colten H. R. Human factor H deficiency. Mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism. J Biol Chem. 1997 Oct 3;272(40):25168–25175. doi: 10.1074/jbc.272.40.25168. [DOI] [PubMed] [Google Scholar]
  6. Bing D. H., Almeda S., Isliker H., Lahav J., Hynes R. O. Fibronectin binds to the C1q component of complement. Proc Natl Acad Sci U S A. 1982 Jul;79(13):4198–4201. doi: 10.1073/pnas.79.13.4198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bürgin M., Hofmann E., Reutter F. W., Gürtler B. A., Matter L., Briner J., Gloor F. Familial glomerulopathy with giant fibrillar deposits. Virchows Arch A Pathol Anat Histol. 1980;388(3):313–326. doi: 10.1007/BF00430861. [DOI] [PubMed] [Google Scholar]
  8. Dib C., Fauré S., Fizames C., Samson D., Drouot N., Vignal A., Millasseau P., Marc S., Hazan J., Seboun E. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature. 1996 Mar 14;380(6570):152–154. doi: 10.1038/380152a0. [DOI] [PubMed] [Google Scholar]
  9. Fogo A., Qureshi N., Horn R. G. Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy. Am J Kidney Dis. 1993 Sep;22(3):367–377. doi: 10.1016/s0272-6386(12)70138-5. [DOI] [PubMed] [Google Scholar]
  10. Gemperle O., Neuweiler J., Reutter F. W., Hildebrandt F., Krapf R. Familial glomerulopathy with giant fibrillar (fibronectin-positive) deposits: 15-year follow-up in a large kindred. Am J Kidney Dis. 1996 Nov;28(5):668–675. doi: 10.1016/s0272-6386(96)90247-4. [DOI] [PubMed] [Google Scholar]
  11. Hildebrandt F., Pohlmann A., Omran H. LODVIEW: a computer program for the graphical evaluation of lod score results in exclusion mapping of human disease genes. Comput Biomed Res. 1993 Dec;26(6):592–599. doi: 10.1006/cbmr.1993.1042. [DOI] [PubMed] [Google Scholar]
  12. Hildebrandt F., Singh-Sawhney I., Schnieders B., Centofante L., Omran H., Pohlmann A., Schmaltz C., Wedekind H., Schubotz C., Antignac C. Mapping of a gene for familial juvenile nephronophthisis: refining the map and defining flanking markers on chromosome 2. APN Study Group. Am J Hum Genet. 1993 Dec;53(6):1256–1261. [PMC free article] [PubMed] [Google Scholar]
  13. Hildebrandt F., Strahm B., Prochoroff A., Cybulla M., Gemperle O., Krapf R., Brandis M. Glomerulopathy associated with predominant fibronectin deposits: exclusion of the genes for fibronectin, villin and desmin as causative genes. Am J Med Genet. 1996 May 3;63(1):323–327. doi: 10.1002/(SICI)1096-8628(19960503)63:1<323::AID-AJMG54>3.0.CO;2-M. [DOI] [PubMed] [Google Scholar]
  14. Korbet S. M., Schwartz M. M., Lewis E. J. Immunotactoid glomerulopathy. Am J Kidney Dis. 1991 Mar;17(3):247–257. doi: 10.1016/s0272-6386(12)80469-0. [DOI] [PubMed] [Google Scholar]
  15. Kruglyak L., Daly M. J., Reeve-Daly M. P., Lander E. S. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet. 1996 Jun;58(6):1347–1363. [PMC free article] [PubMed] [Google Scholar]
  16. Lathrop G. M., Lalouel J. M., Julier C., Ott J. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci U S A. 1984 Jun;81(11):3443–3446. doi: 10.1073/pnas.81.11.3443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lublin D. M., Lemons R. S., Le Beau M. M., Holers V. M., Tykocinski M. L., Medof M. E., Atkinson J. P. The gene encoding decay-accelerating factor (DAF) is located in the complement-regulatory locus on the long arm of chromosome 1. J Exp Med. 1987 Jun 1;165(6):1731–1736. doi: 10.1084/jem.165.6.1731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mazzucco G., Maran E., Rollino C., Monga G. Glomerulonephritis with organized deposits: a mesangiopathic, not immune complex-mediated disease? A pathologic study of two cases in the same family. Hum Pathol. 1992 Jan;23(1):63–68. doi: 10.1016/0046-8177(92)90013-s. [DOI] [PubMed] [Google Scholar]
  19. O'Connell J. R., Weeks D. E. The VITESSE algorithm for rapid exact multilocus linkage analysis via genotype set-recoding and fuzzy inheritance. Nat Genet. 1995 Dec;11(4):402–408. doi: 10.1038/ng1295-402. [DOI] [PubMed] [Google Scholar]
  20. Saar K., Chrzanowska K. H., Stumm M., Jung M., Nürnberg G., Wienker T. F., Seemanová E., Wegner R. D., Reis A., Sperling K. The gene for the ataxia-telangiectasia variant, Nijmegen breakage syndrome, maps to a 1-cM interval on chromosome 8q21. Am J Hum Genet. 1997 Mar;60(3):605–610. [PMC free article] [PubMed] [Google Scholar]
  21. Steel C. M., Philipson J., Arthur E., Gardiner S. E., Newton M. S., McIntosh R. V. Possibility of EB virus preferentially transforming a subpopulation of human B lymphocytes. Nature. 1977 Dec 22;270(5639):729–731. doi: 10.1038/270729a0. [DOI] [PubMed] [Google Scholar]
  22. Stripp B. R., Lund J., Mango G. W., Doyen K. C., Johnston C., Hultenby K., Nord M., Whitsett J. A. Clara cell secretory protein: a determinant of PCB bioaccumulation in mammals. Am J Physiol. 1996 Oct;271(4 Pt 1):L656–L664. doi: 10.1152/ajplung.1996.271.4.L656. [DOI] [PubMed] [Google Scholar]
  23. Strøm E. H., Banfi G., Krapf R., Abt A. B., Mazzucco G., Monga G., Gloor F., Neuweiler J., Riess R., Stosiek P. Glomerulopathy associated with predominant fibronectin deposits: a newly recognized hereditary disease. Kidney Int. 1995 Jul;48(1):163–170. doi: 10.1038/ki.1995.280. [DOI] [PubMed] [Google Scholar]
  24. Tuttle S. E., Sharma H. M., Bay W., Hebert L. A unique familial lobular glomerulopathy. Arch Pathol Lab Med. 1987 Aug;111(8):726–731. [PubMed] [Google Scholar]
  25. Vollmer M., Krapf R., Hildebrandt F. Exclusion of the uteroglobin gene as a candidate for fibronectin glomerulopathy (GFND) Nephrol Dial Transplant. 1998 Sep;13(9):2417–2418. doi: 10.1093/ndt/13.9.2417. [DOI] [PubMed] [Google Scholar]
  26. Weis J. J., Tedder T. F., Fearon D. T. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc Natl Acad Sci U S A. 1984 Feb;81(3):881–885. doi: 10.1073/pnas.81.3.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Zhang Z., Kundu G. C., Yuan C. J., Ward J. M., Lee E. J., DeMayo F., Westphal H., Mukherjee A. B. Severe fibronectin-deposit renal glomerular disease in mice lacking uteroglobin. Science. 1997 May 30;276(5317):1408–1412. doi: 10.1126/science.276.5317.1408. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES